Table 2.
Key antipsychotic targets + associated drug benefit and AE impact examples.
| Target | Clinical effects associated with antagonism or partial agonism | |
|---|---|---|
| Desired | Adverse effects (AE) | |
| D2(*) | Antipsychotic (positive symptoms) | EPS, prolactin ↑, sexual dysfunction and cognition ↓ |
| D3* | Antipsychotic (negative symptoms) | |
| 5-HT1A* | Anxiolytic, antidepressant, anti-EPS(?) | |
| 5-HT2A | Anti-EPS and –akathisia | |
| 5-HT2C | Appetite/weight ↑ and metabolic effects | |
| H1 | Sedation | Sedation, cognition ↓, appetite/ weight ↑ |
| Alpha1 | Hypotension, sexual dysfunction | |
| Muscarinic | Anti-EPS | Dry mouth, constipation, blurry vision, cognition ↓ |
Partial agonism
Antagonism (Desired and Adverse Effects) or partial agonism (only Desired).